[{"id":"a166dffd-a4d9-41b1-a35d-4a1bdb591889","acronym":"","url":"https://clinicaltrials.gov/study/NCT05571540","created_at":"2022-10-07T13:59:53.577Z","updated_at":"2024-07-02T16:35:59.805Z","phase":"Phase 1/2","brief_title":"Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL","source_id_and_acronym":"NCT05571540","lead_sponsor":"Kunming Hope of Health Hospital","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LstCAR019"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 10/01/2022","start_date":" 10/01/2022","primary_txt":" Primary completion: 01/31/2024","primary_completion_date":" 01/31/2024","study_txt":" Completion: 10/31/2024","study_completion_date":" 10/31/2024","last_update_posted":"2022-11-30"}]